The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life

Eye

Volumn 24, Issue 1, 2010, Pages 29-35

  Gabrielian, A ^a   Hariprasad, S M ^a   Jager, R D ^a   Green, J L ^a   Mieler, W F ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Diabetic retinopathy; Quality of life; Utility; Vision Preference Value Scale (VPVS); Visual Function Questionnaire 25 (VFQ 25)

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; PROLIFERATIVE RETINOPATHY; QUALITY OF LIFE; VISION; VISUAL ACUITY;

EID: 75449109558     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.56     Document Type: Article

References (23)

1. Congdon N, O'Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS et al. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477-485. (Pubitemid 38456282)
2. Sharma S, Oliver-Fernandez A, Liu W, Buchholz P, Walt J. The impact of diabetic retinopathy on health-related quality of life. Curr Opin Ophthalmol 2005; 16: 155-159.
3. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999; 128: 324-330.
4. Lamoureux EL, Hassell JB, Keeffe JE. The impact of diabetic retinopathy on participation in daily living. Arch Ophthalmol 2004; 122: 84-88.
5. Mackenzie PJ, Chang TS, Scott IU, Linder M, Hay D, Feuer WJ et al. Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology 2002; 109: 720-729. (Pubitemid 34270129)
6. Cusick M, SanGiovanni JP, Chew EY, Csaky KG, Hall- Shimel K, Reed GF et al. Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am J Ophthalmol 2005; 139: 1042-1050.
7. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD et al. National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 2001; 119: 1050-1058.
8. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the national eye institute visual function questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Arch Ophthalmol 1998; 116: 1496-1504.
9. Mangione CM, Phillips RS, Seddon JM, Lawrence MG, Cook EF, Dailey R et al. Development of the 'activities of daily vision scale'. A measure of visual functional status. Med Care 1992; 30: 1111-1126.
10. Rosen ES, Mamalis N. Visual Acuity Chart. J Cat Ref Surg 2008; 35: A4.
11. Bass EB, Marsh MJ, Mangione CM, Bressler NM, Childs AL, Dong LM et al. Submacular Surgery Trials Research Group. Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularizationFthe submacular surgery trials vision preference value scale: SST report no. 6. Arch Ophthalmol 2004; 122: 1856-1867.
12. Froberg DG, Kane RL. Methodology for measuring healthcare preferences, II: scaling methods. J Clin Epidemiol 1989; 42(5): 459-471.
13. Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 2001; 5(5): 1-186.
14. Margo CE, Mack WP. Therapeutic decisions involving disparate clinical outcomes: patient preference survey for treatment of central retinal artery occlusion. Ophthalmology 1996; 103: 691-696.
15. Jampel HD, Schwartz GF, Robin AL, Abrams DA, Johnson E, Miller RB. Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol 2003; 121: 540-546.
16. Klein R, Moss SE, Klein BE, Gutierrez P, Mangione CM. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 2001; 119: 733-740. (Pubitemid 32417380)
17. Brown GC, Brown MM, Sharma S. Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration. Can J Ophthalmol 2000; 35: 127-133.
18. Brown MM, Brown GC, Sharma S. Value-based medicine and vitreoretinal diseases. Curr Opin Ophthalmol 2004; 15: 167-172.
19. Busbee BG, Brown GC, Brown MM. Value-based medicine: a new paradigm to evaluate treatments for vitreoretinal diseases and other medical interventions. Int Ophthalmol Clin 2004; 44: 155-172.
20. Ko GJ, Brown MM, Brown GC. The macroeconomics of vitreoretinal diseases. Curr Opin Ophthalmol 2005; 16: 184-190.
21. Ghazi-Nouri SM, Tranos PG, Rubin GS, Adams ZC, Charteris DG. Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. Br J Ophthalmol 2006; 90: 559-562.
22. Childs AL, Submacular Surgery Trials Research Group. Effect of order of administration of health-related quality of life interview instruments on responses. Qual Life Res 2005; 14: 493-500.
23. Coyne KS, Margolis MK, Kennedy-Martin T, Baker TM, Klein R, Paul MD et al. The impact of diabetic retinopathy: perspectives from patient focus groups. Fam Pract 2004; 21: 447-453.